Su Jili, Lu Eryong, Lu Lijuan, Zhang Chao
Department of Otorhinolaryngology, Head and Neck Surgery The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology Luoyang China.
FEBS Open Bio. 2017 Mar 18;7(5):645-651. doi: 10.1002/2211-5463.12199. eCollection 2017 May.
MicroRNAs (miRNAs) are known to play a regulatory role in various cancers including laryngocarcinoma. MiR-29a-3p is a potential tumor-suppressive miRNA, but its function in laryngocarcinoma is unknown. The purpose of this study was to investigate the roles of miR-29a-3p in laryngocarcinoma. Prominin1 (PROM1) was predicted as a target gene of miR-29a-3p and this was verified using a luciferase reporter assay. Transfection of miR-29a-3p into two laryngocarcinoma cell lines indicated that miR-29a-3p could decrease cell proliferation and enhance the chemotherapy response by targeting PROM1. PROM1 expression was up-regulated in the laryngocarcinoma cells when miR-29a-3p was down-regulated. We found miR-29a-3p expression levels were lower in laryngocarcinoma tissues than in control tissues. We also found that miR-29a-3p expression was negatively correlated with PROM1 expression in laryngocarcinoma tissues. The study demonstrates that miR-29a-3p suppresses cell proliferation in laryngocarcinoma by targeting PROM1.
已知微小RNA(miRNA)在包括喉癌在内的多种癌症中发挥调节作用。MiR-29a-3p是一种潜在的肿瘤抑制性miRNA,但其在喉癌中的功能尚不清楚。本研究的目的是探讨miR-29a-3p在喉癌中的作用。Prominin1(PROM1)被预测为miR-29a-3p的靶基因,并通过荧光素酶报告基因检测进行了验证。将miR-29a-3p转染到两种喉癌细胞系中表明,miR-29a-3p可通过靶向PROM1降低细胞增殖并增强化疗反应。当miR-29a-3p下调时,喉癌细胞中PROM1表达上调。我们发现喉癌组织中miR-29a-3p表达水平低于对照组织。我们还发现喉癌组织中miR-29a-3p表达与PROM1表达呈负相关。该研究表明,miR-29a-3p通过靶向PROM1抑制喉癌细胞增殖。